We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AquaBounty Technologies Inc | NASDAQ:AQB | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.003 | -0.15% | 1.97 | 0.25 | 2.50 | 1.98 | 1.90 | 1.95 | 11,716 | 05:00:05 |
|
|
|
Delaware
|
04-3156167
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
Common Stock, par value $0.001 per share
|
AQB
|
The NASDAQ Stock Market LLC
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer
þ
|
Smaller reporting company ☐
|
|
|
|
Emerging growth company
þ
|
|
AquaBounty Technologies, Inc.
|
||
FORM 10-Q
|
||
For the Quarterly Period Ended March 31, 2019
|
||
|
||
TABLE OF CONTENTS
|
||
|
||
Page
|
||
|
||
|
|
As of
|
||||||
|
|
March 31,
|
|
December 31,
|
||||
|
|
2019
|
|
2018
|
||||
Assets
|
|
|
|
|
||||
Current assets:
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
7,630,376
|
|
|
$
|
2,990,196
|
|
Certificate of deposit
|
|
12,606
|
|
|
12,361
|
|
||
Other receivables
|
|
136,903
|
|
|
115,982
|
|
||
Inventory
|
|
159,131
|
|
|
76,109
|
|
||
Prepaid expenses and other current assets
|
|
261,176
|
|
|
315,969
|
|
||
Total current assets
|
|
8,200,192
|
|
|
3,510,617
|
|
||
|
|
|
|
|
||||
Property, plant and equipment, net
|
|
23,934,625
|
|
|
23,716,768
|
|
||
Right of use assets, net
|
|
454,890
|
|
|
—
|
|
||
Definite-lived intangible assets, net
|
|
167,866
|
|
|
171,292
|
|
||
Indefinite-lived intangible assets
|
|
191,800
|
|
|
191,800
|
|
||
Other assets
|
|
80,583
|
|
|
80,583
|
|
||
Total assets
|
|
$
|
33,029,956
|
|
|
$
|
27,671,060
|
|
|
|
|
|
|
||||
Liabilities and stockholders’ equity
|
|
|
|
|
||||
Current liabilities:
|
|
|
|
|
||||
Accounts payable and accrued liabilities
|
|
$
|
958,058
|
|
|
$
|
824,900
|
|
Other current liabilities
|
|
84,253
|
|
|
20,423
|
|
||
Current debt
|
|
90,200
|
|
|
71,613
|
|
||
Total current liabilities
|
|
1,132,511
|
|
|
916,936
|
|
||
|
|
|
|
|
||||
Long-term lease obligations
|
|
399,935
|
|
|
—
|
|
||
Long-term debt
|
|
3,941,010
|
|
|
3,519,821
|
|
||
Total liabilities
|
|
5,473,456
|
|
|
4,436,757
|
|
||
|
|
|
|
|
||||
Commitments and contingencies
|
|
|
|
|
|
|
||
|
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
|
||||
Common stock, $0.001 par value, 50,000,000 shares authorized;
|
|
|
|
|
||||
18,697,477 (2018: 15,098,837) shares outstanding
|
|
18,697
|
|
|
15,099
|
|
||
Additional paid-in capital
|
|
149,702,936
|
|
|
142,707,957
|
|
||
Accumulated other comprehensive loss
|
|
(486,635
|
)
|
|
(574,186
|
)
|
||
Accumulated deficit
|
|
(121,678,498
|
)
|
|
(118,914,567
|
)
|
||
Total stockholders’ equity
|
|
27,556,500
|
|
|
23,234,303
|
|
||
|
|
|
|
|
||||
Total liabilities and stockholders’ equity
|
|
$
|
33,029,956
|
|
|
$
|
27,671,060
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
||||
Revenues
|
|
|
|
|
||||
Product revenues
|
|
$
|
97,885
|
|
|
$
|
19,097
|
|
|
|
|
|
|
||||
Costs and expenses
|
|
|
|
|
||||
Product costs
|
|
81,613
|
|
|
16,232
|
|
||
Sales and marketing
|
|
71,991
|
|
|
81,647
|
|
||
Research and development
|
|
663,481
|
|
|
977,817
|
|
||
General and administrative
|
|
2,036,493
|
|
|
1,386,873
|
|
||
Total costs and expenses
|
|
2,853,578
|
|
|
2,462,569
|
|
||
|
|
|
|
|
||||
Operating loss
|
|
(2,755,693
|
)
|
|
(2,443,472
|
)
|
||
|
|
|
|
|
||||
Other income (expense)
|
|
|
|
|
||||
Gain on disposal of equipment
|
|
—
|
|
|
1,160
|
|
||
Interest expense
|
|
(13,338
|
)
|
|
(5,402
|
)
|
||
Other income (expense), net
|
|
5,100
|
|
|
(2,073
|
)
|
||
Total other income (expense)
|
|
(8,238
|
)
|
|
(6,315
|
)
|
||
|
|
|
|
|
||||
Net loss
|
|
$
|
(2,763,931
|
)
|
|
$
|
(2,449,787
|
)
|
|
|
|
|
|
||||
Other comprehensive income (loss):
|
|
|
|
|
||||
Foreign currency translation income (loss)
|
|
87,551
|
|
|
(112,118
|
)
|
||
Total other comprehensive income (loss)
|
|
87,551
|
|
|
(112,118
|
)
|
||
|
|
|
|
|
||||
Comprehensive loss
|
|
$
|
(2,676,380
|
)
|
|
$
|
(2,561,905
|
)
|
|
|
|
|
|
||||
|
|
|
|
|
||||
Basic and diluted net loss per share
|
|
$
|
(0.18
|
)
|
|
$
|
(0.21
|
)
|
Weighted average number of common shares -
|
|
|
|
|
||||
basic and diluted
|
|
15,687,681
|
|
|
11,940,874
|
|
||
|
|
|
|
|
|
|
Common stock issued and outstanding
|
|
Par value
|
|
Additional paid-in capital
|
|
Accumulated other comprehensive loss
|
|
Accumulated deficit
|
|
Total
|
|||||||||||
Balance at December 31, 2018
|
|
15,098,837
|
|
|
$
|
15,099
|
|
|
$
|
142,707,957
|
|
|
$
|
(574,186
|
)
|
|
$
|
(118,914,567
|
)
|
|
$
|
23,234,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss
|
|
|
|
|
|
|
|
|
|
(2,763,931
|
)
|
|
(2,763,931
|
)
|
|||||||||
Other comprehensive loss
|
|
|
|
|
|
|
|
87,551
|
|
|
|
|
87,551
|
|
|||||||||
Issuance of common stock, net of expenses
|
|
3,345,282
|
|
|
3,345
|
|
|
6,606,310
|
|
|
|
|
|
|
6,609,655
|
|
|||||||
Exercise of warrants for common stock
|
|
76,797
|
|
|
77
|
|
|
250,347
|
|
|
|
|
|
|
250,424
|
|
|||||||
Share based compensation
|
|
176,561
|
|
|
176
|
|
|
138,322
|
|
|
|
|
|
|
138,498
|
|
|||||||
Balance at March 31, 2019
|
|
18,697,477
|
|
|
$
|
18,697
|
|
|
$
|
149,702,936
|
|
|
$
|
(486,635
|
)
|
|
$
|
(121,678,498
|
)
|
|
$
|
27,556,500
|
|
|
|
Common stock issued and outstanding
|
|
Par value
|
|
Additional paid-in capital
|
|
Accumulated other comprehensive loss
|
|
Accumulated deficit
|
|
Total
|
||||||||||
Balance at December 31, 2017
|
|
8,895,094
|
|
$
|
8,895
|
|
|
$
|
126,718,186
|
|
|
$
|
(213,884
|
)
|
|
$
|
(108,532,508
|
)
|
|
$
|
17,980,689
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
(2,449,787)
|
|
|
(2,449,787)
|
|
||||||||
Other comprehensive loss
|
|
|
|
|
|
|
|
(112,118)
|
|
|
|
|
(112,118)
|
|
||||||||
Issuance of common stock and warrants, net of expenses
|
|
3,692,307
|
|
3,692
|
|
|
10,612,356
|
|
|
|
|
|
|
10,616,048
|
|
|||||||
Exercise of warrants for common stock
|
|
76,981
|
|
77
|
|
|
250,111
|
|
|
|
|
|
|
250,188
|
|
|||||||
Share based compensation
|
|
11,151
|
|
12
|
|
|
48,534
|
|
|
|
|
|
|
48,546
|
|
|||||||
Balance at March 31, 2018
|
|
12,675,533
|
|
$
|
12,676
|
|
|
$
|
137,629,187
|
|
|
$
|
(326,002
|
)
|
|
$
|
(110,982,295
|
)
|
|
$
|
26,333,566
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
||||
Operating activities
|
|
|
|
|
||||
Net loss
|
|
$
|
(2,763,931
|
)
|
|
$
|
(2,449,787
|
)
|
Adjustment to reconcile net loss to net cash used in
|
|
|
|
|
||||
operating activities:
|
|
|
|
|
||||
Depreciation and amortization
|
|
285,308
|
|
|
67,450
|
|
||
Share-based compensation
|
|
138,498
|
|
|
48,546
|
|
||
Gain on disposal of equipment
|
|
—
|
|
|
(1,160
|
)
|
||
Changes in operating assets and liabilities:
|
|
|
|
|
||||
Other receivables
|
|
(18,410
|
)
|
|
(39,371
|
)
|
||
Inventory
|
|
(83,158
|
)
|
|
46,047
|
|
||
Prepaid expenses and other assets
|
|
55,504
|
|
|
369,621
|
|
||
Accounts payable and accrued liabilities
|
|
253,509
|
|
|
(508,423
|
)
|
||
Net cash used in operating activities
|
|
(2,132,680
|
)
|
|
(2,467,077
|
)
|
||
|
|
|
|
|
||||
Investing activities
|
|
|
|
|
||||
Purchase of property, plant and equipment
|
|
(456,436
|
)
|
|
(2,034,048
|
)
|
||
Proceeds on sale of equipment
|
|
—
|
|
|
1,173
|
|
||
Other investing activities
|
|
13
|
|
|
—
|
|
||
Net cash used in investing activities
|
|
(456,423
|
)
|
|
(2,032,875
|
)
|
||
|
|
|
|
|
||||
Financing activities
|
|
|
|
|
||||
Proceeds from issuance of debt
|
|
376,117
|
|
|
—
|
|
||
Repayment of term debt
|
|
(9,619
|
)
|
|
(14,168
|
)
|
||
Proceeds from the issuance of common stock and warrants, net
|
|
6,609,655
|
|
|
10,616,048
|
|
||
Proceeds from the exercise of stock options and warrants, net
|
|
250,424
|
|
|
250,188
|
|
||
Net cash provided by financing activities
|
|
7,226,577
|
|
|
10,852,068
|
|
||
|
|
|
|
|
||||
Effect of exchange rate changes on cash and cash equivalents
|
|
2,706
|
|
|
(5,588
|
)
|
||
Net change in cash and cash equivalents
|
|
4,640,180
|
|
|
6,346,528
|
|
||
Cash and cash equivalents at beginning of period
|
|
2,990,196
|
|
|
492,861
|
|
||
Cash and cash equivalents at the end of period
|
|
$
|
7,630,376
|
|
|
$
|
6,839,389
|
|
|
|
|
|
|
||||
Supplemental disclosure of cash flow information and
|
|
|
|
|
||||
non-cash transactions:
|
|
|
|
|
||||
Interest paid in cash
|
|
$
|
13,338
|
|
|
$
|
5,402
|
|
Property and equipment included in accounts payable and accrued liabilities
|
|
$
|
79,193
|
|
|
$
|
976,208
|
|
Acquisition of equipment under debt arrangement
|
|
$
|
—
|
|
|
$
|
75,911
|
|
|
|
March 31,
|
|
December 31,
|
||||
|
|
2019
|
|
2018
|
||||
Feed
|
|
$
|
44,236
|
|
|
$
|
24,288
|
|
Eggs
|
|
30,405
|
|
|
—
|
|
||
Packaging
|
|
4,554
|
|
|
8,913
|
|
||
Fish in process
|
|
79,936
|
|
|
42,908
|
|
||
Total inventory
|
|
$
|
159,131
|
|
|
$
|
76,109
|
|
|
|
March 31,
|
|
December 31,
|
||||
|
|
2019
|
|
2018
|
||||
Land
|
|
$
|
711,336
|
|
|
$
|
704,567
|
|
Building and improvements
|
|
9,284,732
|
|
|
9,244,737
|
|
||
Construction in process
|
|
6,545,566
|
|
|
6,091,265
|
|
||
Equipment
|
|
9,743,545
|
|
|
9,713,030
|
|
||
Office furniture and equipment
|
|
193,333
|
|
|
192,606
|
|
||
Vehicles
|
|
27,391
|
|
|
26,832
|
|
||
Total property and equipment
|
|
$
|
26,505,903
|
|
|
$
|
25,973,037
|
|
Less accumulated depreciation and amortization
|
|
(2,571,278
|
)
|
|
(2,256,269
|
)
|
||
Property, plant and equipment, net
|
|
$
|
23,934,625
|
|
|
$
|
23,716,768
|
|
|
|
March 31,
|
|
December 31,
|
||||
|
|
2019
|
|
2018
|
||||
Accounts payable
|
|
$
|
279,471
|
|
|
$
|
366,917
|
|
Accrued payroll including vacation
|
|
195,922
|
|
|
223,481
|
|
||
Accrued professional fees and research costs
|
|
344,635
|
|
|
185,992
|
|
||
Accrued franchise and excise taxes
|
|
117,747
|
|
|
23,678
|
|
||
Accrued construction costs
|
|
4,503
|
|
|
13,716
|
|
||
Accrued other
|
|
15,780
|
|
|
11,116
|
|
||
Accounts payable and accrued liabilities
|
|
$
|
958,058
|
|
|
$
|
824,900
|
|
Original loan amount
|
|
Interest
rate |
|
Monthly
repayment |
|
Maturity
date |
|
March 31, 2019
|
|
December 31, 2018
|
||||
ACOA AIF grant (C$2,871,919)
|
|
0%
|
|
Royalties
|
|
-
|
|
$
|
2,150,780
|
|
|
$
|
2,106,840
|
|
ACOA term loan (C$337,000)
|
|
0%
|
|
C$3,120
|
|
June 2026
|
|
200,975
|
|
|
203,735
|
|
||
ACOA term loan (C$500,000)
|
|
0%
|
|
C$4,630
|
|
November 2028
|
|
374,450
|
|
|
—
|
|
||
Kubota Canada Ltd. (C$95,961)
|
|
0%
|
|
C$1,142
|
|
January 2025
|
|
59,887
|
|
|
61,178
|
|
||
Finance PEI term loan (C$2,717,093)
|
|
4%
|
|
C$4,333
|
|
July 2021
|
|
1,245,118
|
|
|
1,219,681
|
|
||
Total debt
|
|
|
|
|
|
|
|
$
|
4,031,210
|
|
|
$
|
3,591,434
|
|
less: current portion
|
|
|
|
|
|
|
|
(90,200
|
)
|
|
(71,613
|
)
|
||
Long-term debt
|
|
|
|
|
|
|
|
$
|
3,941,010
|
|
|
$
|
3,519,821
|
|
Year
|
|
AIF
|
|
ACOA
|
|
FPEI
|
|
Kubota
|
|
Total
|
||||||||||
2019
|
|
$
|
—
|
|
|
$
|
21,029
|
|
|
$
|
30,964
|
|
|
$
|
7,700
|
|
|
$
|
59,693
|
|
2020
|
|
—
|
|
|
69,648
|
|
|
42,754
|
|
|
10,266
|
|
|
122,668
|
|
|||||
2021
|
|
—
|
|
|
69,648
|
|
|
44,496
|
|
|
10,266
|
|
|
124,410
|
|
|||||
2022
|
|
—
|
|
|
69,648
|
|
|
46,309
|
|
|
10,266
|
|
|
126,223
|
|
|||||
2023
|
|
—
|
|
|
69,648
|
|
|
1,080,595
|
|
|
10,266
|
|
|
1,160,509
|
|
|||||
Thereafter
|
|
2,150,780
|
|
|
275,804
|
|
|
—
|
|
|
11,123
|
|
|
2,437,707
|
|
|||||
Total
|
|
$
|
2,150,780
|
|
|
$
|
575,425
|
|
|
$
|
1,245,118
|
|
|
$
|
59,887
|
|
|
$
|
4,031,210
|
|
|
|
|
|
March 31, 2019
|
|
January 1, 2019
|
||||||||||
|
Lease Type
|
End Date
|
Remaining Years
|
Remaining Payments
|
Lease Liability
|
|
Remaining Payments
|
Lease Liability
|
||||||||
Maynard Office Lease
|
Operating
|
Mar 2023
|
4.00
|
$
|
262,847
|
|
$
|
222,931
|
|
|
$
|
278,414
|
|
$
|
234,685
|
|
Panama Farm Lease
|
Operating
|
Apr 2019
|
0.08
|
15,000
|
|
14,901
|
|
|
60,000
|
|
59,013
|
|
||||
Indiana Auto Lease
|
Operating
|
Feb 2021
|
1.92
|
9,631
|
|
8,838
|
|
|
10,842
|
|
9,897
|
|
||||
Indiana Well Lease
|
Operating
|
Dec 2048
|
29.78
|
713,650
|
|
227,442
|
|
|
717,420
|
|
228,844
|
|
||||
Total leases
|
|
|
|
$
|
1,001,128
|
|
$
|
474,112
|
|
|
$
|
1,066,676
|
|
$
|
532,439
|
|
Less: current portion
|
|
|
|
(98,338
|
)
|
(74,177
|
)
|
|
(142,780
|
)
|
(117,345
|
)
|
||||
Long-term leases
|
|
|
|
$
|
902,790
|
|
$
|
399,935
|
|
|
$
|
923,896
|
|
$
|
415,094
|
|
Year
|
|
Office
|
Farm
|
Auto
|
Well
|
Amount
|
||||||||||
2019
|
|
$
|
47,292
|
|
$
|
15,000
|
|
$
|
3,632
|
|
$
|
11,310
|
|
$
|
77,234
|
|
2020
|
|
64,637
|
|
—
|
|
4,842
|
|
15,532
|
|
85,011
|
|
|||||
2021
|
|
66,416
|
|
—
|
|
1,157
|
|
15,998
|
|
83,571
|
|
|||||
2022
|
|
67,602
|
|
—
|
|
—
|
|
16,478
|
|
84,080
|
|
|||||
2023
|
|
16,900
|
|
—
|
|
—
|
|
16,972
|
|
33,872
|
|
|||||
Thereafter
|
|
—
|
|
—
|
|
—
|
|
637,360
|
|
637,360
|
|
|||||
Total Lease Payments
|
|
$
|
262,847
|
|
$
|
15,000
|
|
$
|
9,631
|
|
$
|
713,650
|
|
$
|
1,001,128
|
|
|
|
Number of
warrant shares
|
|
Weighted
average
exercise price
|
|||
Outstanding at December 31, 2018
|
|
1,745,868
|
|
|
|
$3.25
|
|
Exercised
|
|
(76,797
|
)
|
|
3.25
|
|
|
Outstanding at March 31, 2019
|
|
1,669,071
|
|
|
|
$3.25
|
|
Exercisable at March 31, 2019
|
|
1,669,071
|
|
|
|
$3.25
|
|
|
|
Shares
|
|
Weighted
average grant
date fair value
|
|||
Balance at December 31, 2018
|
|
8,867
|
|
|
|
$3.51
|
|
Granted
|
|
176,561
|
|
|
2.13
|
|
|
Vested
|
|
(40,623
|
)
|
|
2.21
|
|
|
Balance at March 31, 2019
|
|
144,805
|
|
|
|
$2.19
|
|
|
|
Number of
options
|
|
Weighted
average
exercise price
|
|||
Outstanding at December 31, 2018
|
|
339,964
|
|
|
|
$7.09
|
|
Issued
|
|
7,500
|
|
|
2.11
|
|
|
Outstanding at March 31, 2019
|
|
347,464
|
|
|
|
$6.98
|
|
Exercisable at March 31, 2019
|
|
326,382
|
|
|
|
$6.77
|
|
Weighted average exercise price of outstanding options
|
|
Number of options outstanding
|
|
Weighted average remaining estimated life (in years)
|
|
Number of options exercisable
|
|
Weighted average exercise price of outstanding and exercisable options
|
||
$2.50 - $5.70
|
|
211,534
|
|
|
5.5
|
|
204,568
|
|
|
|
$6.90 - $9.60
|
|
53,175
|
|
|
3.5
|
|
53,175
|
|
|
|
$10.50 - $10.80
|
|
4,000
|
|
|
4.9
|
|
4,000
|
|
|
|
$14.20 - $23.40
|
|
78,755
|
|
|
7.0
|
|
64,639
|
|
|
|
|
|
347,464
|
|
|
|
|
326,382
|
|
|
$6.77
|
•
|
salaries and related overhead expenses for personnel in research and development functions;
|
•
|
fees paid to contract research organizations, Intrexon, and consultants who perform research for us;
|
•
|
costs related to laboratory supplies used in our research and development efforts;
|
•
|
costs related to the operation of our field trials; and
|
•
|
costs related to the grow-out of fish at the Panama site that are not capitalized in inventory.
|
|
|
Three Months Ended
March 31,
|
|
Dollar
Change
|
|
%
Change
|
|||||||||
|
|
2019
|
|
2018
|
|
|
|||||||||
|
|
(unaudited)
|
|
|
|
|
|||||||||
Product revenue
|
|
$
|
98
|
|
|
$
|
19
|
|
|
$
|
79
|
|
|
416
|
%
|
|
|
|
|
|
|
|
|
|
|||||||
Operating expenses:
|
|
|
|
|
|
|
|
|
|||||||
Product costs
|
|
82
|
|
|
16
|
|
|
66
|
|
|
413
|
%
|
|||
Sales and marketing
|
|
72
|
|
|
82
|
|
|
(10
|
)
|
|
(12
|
)%
|
|||
Research and development
|
|
663
|
|
|
978
|
|
|
(315
|
)
|
|
(32
|
)%
|
|||
General and administrative
|
|
2,037
|
|
|
1,387
|
|
|
650
|
|
|
47
|
%
|
|||
Operating loss
|
|
2,756
|
|
|
2,444
|
|
|
312
|
|
|
13
|
%
|
|||
Total other (income) expense
|
|
8
|
|
|
6
|
|
|
2
|
|
|
33
|
%
|
|||
Net loss
|
|
$
|
2,764
|
|
|
$
|
2,450
|
|
|
$
|
314
|
|
|
13
|
%
|
|
Three Months Ended
March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
(unaudited)
|
||||||
Net cash provided by (used in):
|
|
|
|
||||
Operating activities
|
$
|
(2,133
|
)
|
|
$
|
(2,467
|
)
|
Investing activities
|
(456
|
)
|
|
(2,033
|
)
|
||
Financing activities
|
7,226
|
|
|
10,852
|
|
||
Effect of exchange rate changes on cash
|
3
|
|
|
(5
|
)
|
||
Net increase (decrease) in cash
|
$
|
4,640
|
|
|
$
|
6,347
|
|
•
|
the timing of additional regulatory approvals and permits for AquAdvantage Salmon, if any;
|
•
|
the cost to complete construction activities at our Rollo Bay site;
|
•
|
the cost to raise fish at our Indiana and Rollo Bay sites; and
|
•
|
the timing of costs related to the FDA legal challenge (see “Legal Proceedings,” below).
|
|
|
AQUABOUNTY TECHNOLOGIES, INC.
|
|
|
|
May 2, 2019
|
|
/s/ Sylvia Wulf
|
|
|
Sylvia Wulf
|
|
|
President, Chief Executive Officer, and Director (Principal Executive Officer)
|
|
|
|
May 2, 2019
|
|
/s/ David A. Frank
|
|
|
David A. Frank
|
|
|
Chief Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer)
|
1 Year AquaBounty Technologies Chart |
1 Month AquaBounty Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions